New Integrated Biologics Solution Center

Article

Sponsored Content

WuXi has started construction of a state-of-the-art, integrated R&D and manufacturing center at the company's headquarters (see press release). This 250,000 sq. ft. facility will be operational in 2017 and can accommodate 800 scientists.  The center will provide comprehensive concept to clinic biologics discovery, development, and GMP manufacturing services on one consolidated campus. This facility utilizes WuXi’s single-source technology platforms.

WuXi Biologics (A wholly owned subsidiary of WuXi AppTec)
info@wuxibiologics.comwww.wuxibiologics.com/news-events/#WXnews

Recent Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.